Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 29, 2013
Rational design of boradiazaindacene (BODIPY)-based functional molecules
Monika Gupta, Soumyaditya Mula, Mrityunjay Tyagi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 28, 2018
Resveratrol analogue, trans-4,4'-dihydroxystilbene (DHS), inhibits melanoma tumor growth and suppresses its metastatic colonization in lungs
Bhaskar Saha, Ganesh B Pai, Mahesh Subramanian, et al.
Biomacromolecules
|
June 10, 2025
Robust Hydrogen-Bonded Organic Framework for pH-Responsive Drug Delivery
Sucheta Chatterjee, Mrityunjay Tyagi, Ayan Ghosh, et al.
Nature Structural & Molecular Biology
|
December 19, 2022
Polλ promotes microhomology-mediated end-joining
Gurushankar Chandramouly, Joonas Jamsen, Nikita Borisonnik, et al.
Nature Communications
|
July 10, 2024
PARG is essential for Polθ-mediated DNA end-joining by removing repressive poly-ADP-ribose marks
Umeshkumar Vekariya, Leonid Minakhin, Gurushankar Chandramouly, et al.
Nature Communications
|
August 14, 2024
Structural basis for a Polθ helicase small-molecule inhibitor revealed by cryo-EM
Fumiaki Ito, Ziyuan Li, Leonid Minakhin, et al.
Scientific Reports
|
December 22, 2021
Carbon nano-dot for cancer studies as dual nano-sensor for imaging intracellular temperature or pH variation
Trilochan Gadly, Goutam Chakraborty, Mrityunjay Tyagi, et al.
Journal of Medicinal Chemistry
|
October 22, 2025
RTx-303, an Orally Bioavailable Polθ Polymerase Inhibitor That Potentiates PARP Inhibitors in BRCA Mutant Tumors
Gurushankar Chandramouly, William Fried, John Gordon, et al.
Nature Communications
|
April 5, 2024
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
William Fried, Mrityunjay Tyagi, Leonid Minakhin, et al.
Molecular Cancer Therapeutics
|
December 8, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress
Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Chemistry (Weinheim an Der Bergstrasse, Germany)
|
November 29, 2013
Rational design of boradiazaindacene (BODIPY)-based functional molecules
Monika Gupta, Soumyaditya Mula, Mrityunjay Tyagi, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
September 28, 2018
Resveratrol analogue, trans-4,4'-dihydroxystilbene (DHS), inhibits melanoma tumor growth and suppresses its metastatic colonization in lungs
Bhaskar Saha, Ganesh B Pai, Mahesh Subramanian, et al.
Biomacromolecules
|
June 10, 2025
Robust Hydrogen-Bonded Organic Framework for pH-Responsive Drug Delivery
Sucheta Chatterjee, Mrityunjay Tyagi, Ayan Ghosh, et al.
Nature Structural & Molecular Biology
|
December 19, 2022
Polλ promotes microhomology-mediated end-joining
Gurushankar Chandramouly, Joonas Jamsen, Nikita Borisonnik, et al.
Nature Communications
|
July 10, 2024
PARG is essential for Polθ-mediated DNA end-joining by removing repressive poly-ADP-ribose marks
Umeshkumar Vekariya, Leonid Minakhin, Gurushankar Chandramouly, et al.
Nature Communications
|
August 14, 2024
Structural basis for a Polθ helicase small-molecule inhibitor revealed by cryo-EM
Fumiaki Ito, Ziyuan Li, Leonid Minakhin, et al.
Scientific Reports
|
December 22, 2021
Carbon nano-dot for cancer studies as dual nano-sensor for imaging intracellular temperature or pH variation
Trilochan Gadly, Goutam Chakraborty, Mrityunjay Tyagi, et al.
Journal of Medicinal Chemistry
|
October 22, 2025
RTx-303, an Orally Bioavailable Polθ Polymerase Inhibitor That Potentiates PARP Inhibitors in BRCA Mutant Tumors
Gurushankar Chandramouly, William Fried, John Gordon, et al.
Nature Communications
|
April 5, 2024
Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors
William Fried, Mrityunjay Tyagi, Leonid Minakhin, et al.
Molecular Cancer Therapeutics
|
December 8, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress
Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams, et al.
Page
of 2